Docdata on the disposal of its entire business by a coordinated simultaneous sale of both its businesses valued around EUR 200 million.Binck Bank on Saxo Bank's recommended public offer.Arvelle Therapeutics Series A financing up to USD and inlicensing from SK Biopharmaceuticals with an upfront payment of USD 100 million with a future milestone potential of up to USD 430.Mylan's USD 22 bn merger with Pfizer division Upjohn.Sybren develops multifaceted bespoke solutions to client challenges by leveraging a wide breadth of experience in M&A, a pragmatic approach and a solid business sense. He focusses his practice primarily on public and private cross-border deals and venture capital funding and has a sector specific focus on the tech and life sciences industry. Sybren de Beurs is a partner at the Corporate M&A practice of NautaDutilh's Amsterdam office.
0 Comments
Leave a Reply. |